Issue link: http://www.e-digitaleditions.com/i/751389
Tablets & Capsules November 2016 15 Good distribution practices. Linda Herzog. Eye on Excipients, May 2011, p. 21. HPMC capsules gain credibility as alternative to gelatin. Ken Seufert and Kirti Vatsa, September 2016, p. 41. High-functionality excipients: A review. Nandu Deorkar. July 2008, p. 22. How excipients can help when the product pipeline is shrinking. Eye on Excipients, Hans Huttinga. September 2008, p. 45. How to qualify new excipients. Maria Guazzaroni Jacobs, R. Christian Moreton, and Irwin Silverstein. Eye on Excipients, May 2008, p. 45. Hydroxypropyl methylcellulose. John A. McCarty. Eye on Excipients, March 2008, p. 47 and April 2010, p. 39. Hydroxypropyl starch. Xavier Parissaux, Ashish A. Joshi, and Gregory Le Bihan. Eye on Excipients, April 2008, p. 51. IPEC conference. John A. McCarty. Eye on Excipients, March 2006, p. 57. IPEC regulatory affairs conference 2007. John A. McCarty. Eye on Excipients, January 2008, p. 52. IPEC regulatory affairs conference 2008. John A. McCarty. Eye on Excipients, October 2008, p. 61. IPEC regulatory affairs conference 2009. John A. McCarty. Eye on Excipients, January 2010, p. 31. The importance of excipients in dietary supplements. Ashish Gandhi. April 2013, p. 32C. Impurities. John A. McCarty. Eye on Excipients, March 2012, p. 37. Isomalt. Bodo Fritzsching, Maj-Britt Babbel, and Oliver Luhn. Eye on Excipients, May 2007, p. 43. Isomalt. Maj-Britt Cepok and Bodo Fritzsching. Eye on Excipients, September 2011, p. 53. Lactose for use in dry powder inhaler formulations. Sabine Hauptstein, Mirjam Kobler, Eva Littringer, and Eugen Schwarz. Eye on Excipients, October 2016, p. 41. Low-viscosity HPCs. Ryan Cheng. Eye on Excipients, October 2014, p. 37. Magnesium stearate. John A. McCarty. Eye on Excipients, January 2007, p. 53. Magnesium stearate: Deal yourself a winning hand. Pieter Gommans. July 2009, p. 20. Making bitter-tasting APIs palatable using the right combi- nation of excipients. Bob Oas. July 2006, p. 12. Maltodextrin. Carrie Shipley. Eye on Excipients, October 2011, p. 41. Mannitol. John A. McCarty. Eye on Excipients, April 2006, p. 41. Manufacturing orally disintegrating tablets using co- processed excipients. Eye on Excipients, Komal Shahani, Nandu Deorkar, and Anil Gandhi. March 2011, p. 37. Microcrystalline cellulose. John A. McCarty. Eye on Excipients, September 2006, p. 53. Microcrystalline cellulose. Kazuhiro Obae, Yosuke Honda, and Takumi Magome. Eye on Excipients, March 2009, p. 45. Moisture-induced antiplasticization in microcrystalline cel- lulose compacts. Sai Prasanth Chamarthy and Rodolfo Pinal. July 2007, p. 22. Options for conducting elemental impurities testing. Timothy Klock. Back Page, July 2016, p. 48. Properties of mucoadhesive polymers and their use in tablets and other dosage forms. Elena Draganoiu. July 2016, p. 17. New excipients for solubilizing APIs: Expansion of the HPMCAS chemistry space. Michael Morgen, David Lyon, Robert Schmitt, Meinolf Brackhagen, and Oliver Petermann. July 2013, p. 10. A new framework for using new excipients? Matthew Knopp. Eye on Excipients, January 2014, p. 39. New IPEC excipients initiatives—Quality by Design. David R. Schoneker. Back Page, July 2007, p. 80. The "non-critical" excipient: Does it exist? Brian Carlin. Back Page, July 2012, p. 48. On-site audits of excipient suppliers. Irwin B. Silverstein and Jim Morris. Eye on Excipients, September 2014, p. 41. Pediatric formulations. Alen Guy. Eye on Excipients, April 2013, p. 37. ODT delivery platforms: A comparison of dissolution times. H.-Leonhard Ohrem, Guenter Moddelmog, and Roberto Ognibene. October 2010, p. 14. Pharmaceutical colors: A different perspective. Brian E. Jones. Back Page, January 2007, p. 68. Polyethylene glycols. John A. McCarty. Eye on Excipients, September 2007, p. 59. Porous silica gel: An ideal solid hydrophilic carrier for oils and other liquids. Raghunadha Gupta, Chitra Sundararajan, Thomas Pauly, and Fred Monsuur. July 2012, p. 14. Process improvement: Is it always win-win? Yury Lagoviyer. Back Page, July 2011, p. 48. QbD and co-processed excipients: A low-risk alternative to API-in-capsule for expediting first-in-human studies. Adam Lambert. March 2014, p. 18. A Quality-by-Design comparison of two film coating sys- tems. Brian Cheng. April 2013, p. 12. Rebranding lipophilic excipients. Shaukat Ali and Thomas Rosen. Eye on Excipients, April 2012, p. 41. Ribus offers natural alternative to silicon dioxide. January 2015, p. 32B. The role of excipient distributors. Linda Herzog. Eye on Excipients, September 2016, p. 53. Safety evaluations of new excipients. Christopher DeMerlis, Elaine V. Knight, R. Christian Moreton, and Robert E. Osterberg. Eye on Excipients, April 2011, p. 33. Selection of non-synthetic disintegrants for pharmaceutical and nutraceutical orally disintegrating tablets. Carmen Popescu, Liuming Zhou, Ashish Joshi, Hong Liu, Alain Francois, Delphine Damour, and Philippe LeFevre. July 2010, p. 14. i n d e x t o a r t i c l e s